July 16, 2015 |
Mayor Nutter was set to depart Tuesday night for a six-day trade mission to Germany and Israel, to encourage companies there to do business in Philadelphia and local firms to expand into those foreign markets. He was scheduled to fly first to Frankfurt and sign a sister-city agreement. "I think there's a synergy between and among our cities. There's a very strong German American community here in Philadelphia, one of the first that was settled in the United States," Nutter said in brief remarks at City Hall before departing.
September 10, 2014 |
The list is long of the perfect accompaniments to beer: hot dogs, pizza, peanuts, and pretzels, to name just a few. Most definitely not on that list: pediococcus and lactobacillus. Consider them beer buzzkills. These are types of bacteria that often hitch a ride into breweries aboard grain. If they make their way into the beer itself, they can spoil taste by producing lactic acid, a chemical compound most commonly associated with sore muscles after exertion and first refined in 1780 from sour milk.
July 7, 2013 |
Rosalind Echols' teaching methods are not exactly conventional. So instead of spending the summer reading up on the scientific method to write a lesson plan, she will cruise through Alaskan waters with a team of scientists to see the process in action. Echols, a physics teacher at Science Leadership Academy in Center City, uses real-life experience in her classes. One of her favorite assignments is to ask students to study the subway to see how force causes riders to stumble if they don't grab a handbar.
April 9, 2013 |
For 50 years, the University City Science Center has been where scientists and start-ups have toiled to build the next generation of Philadelphia-area companies. But to hear science center president and CEO Stephen S. Tang , what would really help nurture that entrepreneurial soup would be if a big life-sciences company were to put its headquarters or research operations in West Philadelphia. Given that several of the biggest drug companies locally have already made long-term commitments elsewhere, there is nothing on the horizon presently.
December 28, 2012 |
Liquent Inc., of Horsham, has been acquired by Parexel International Corp. for $72 million in cash. Founded in 1994, Liquent develops software that helps more than 200 biopharmaceutical and life-sciences companies manage their regulatory submissions and product registrations. It has about 300 employees at offices in the United Kingdom, Germany, and India, and about 100 at its Montgomery County headquarters. Parexel, of Waltham, Mass., also provides a variety of services to the life-sciences industry, including clinical-trials management, biostatistical analysis, and medical communications.
December 18, 2012 |
The last seven days of news from the region's life-sciences industry was a mix of messages involving expansion, succession, relocation, contraction, and conclusion. Iroko Pharmaceuticals L.L.C. cemented its reputation as a company to watch Wednesday when it celebrated the opening of its new offices at the Navy Yard in South Philadelphia. Begun by veterans of the region's Big Pharma companies, Iroko has grown over the last five years to employ about 60 and could triple the number working in its new 56,412-square-foot building over the next few years.
November 25, 2012 |
The Dutch company Royal DSM N.V. is an example of a global giant that has been able to change its business identity. The "DSM" in the name stands for "Dutch State Mines," but that's about the only remnant of its 1902 beginnings as a state-owned coal-mining company. After World War II, the company expanded into the industrial chemicals business and wound up jettisoning its mining operations. Privatized by the Netherlands in 1989, Royal DSM management sensed the need for another change, said Feike Sijbesma, its current chairman and CEO. Between 2000 and 2010, Royal DSM remade itself again into a life- and materials-sciences firm to reduce its dependence on petroleum.
March 12, 2012 |
Claims that folding Rutgers-Camden into Rowan University will greatly increase area research and development are inflated at best and lack a true accounting of existing resources in South Jersey and how they should be built upon. The merger committee's report necessarily focuses on Cooper Hospital in Camden and the medical school that will open this fall. Through sleight of hand, suddenly a whole portion of the state's flagship research institution, Rutgers University, must be wrested away to make this new entity work.
January 13, 2012 |
I'm not sure what the twists in the local life-sciences sector in early 2012 portend for the year as a whole. Just after New Year's, Ossianix Inc. , a two-person biopharmaceutical company in Philadelphia, attracted investment from a major European drug company called H. Lundbeck A/S . No dollar signs were attached to what was described as a "strategic investment. " But Lundbeck, which had its U.S. commercial headquarters in King of Prussia for a few months in 2006-07, is a major player in treatments for disorders of the central nervous system.
December 8, 2011 |
Itty-bitty bytes of code and mini molecules of future drugs are coming together in a mother lode of data for scientists to examine in a project led by IBM and three other companies in coordination with the National Institutes of Health. Collaborating with Bristol-Myers Squibb, DuPont, and Pfizer, IBM will announce Thursday that it is providing a database of more than 2.4 million chemical compounds extracted from about 4.7 million patents and 11 million biomedical journal abstracts from 1976 to 2000.